UBS AM’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-99,546
Closed -$310K 2555
2023
Q4
$310K Hold
99,546
﹤0.01% 2416
2023
Q3
$599K Hold
99,546
﹤0.01% 2220
2023
Q2
$1.26M Hold
99,546
﹤0.01% 1896
2023
Q1
$1.26M Buy
99,546
+2,217
+2% +$25.6K ﹤0.01% 1896
2022
Q4
$886K Buy
97,329
+5,330
+6% +$57.5K ﹤0.01% 1904
2022
Q3
$1.08M Sell
91,999
-20,847
-18% -$264K ﹤0.01% 1915
2022
Q2
$1.45M Buy
112,846
+16,919
+18% +$227K ﹤0.01% 1768
2022
Q1
$1.62M Buy
95,927
+13,700
+17% +$226K ﹤0.01% 1899
2021
Q4
$1.99M Buy
+82,227
New +$2.12M ﹤0.01% 1876

Other funds holding SKIN

UBS AM's SKIN Position: Q1 2024 in Review

UBS AM sold out of SkinHealth Systems (SKIN) in Q1 2024, closing a stake of 99,546 shares — an estimated $310K sold.

UBS AM first reported a position in SKIN in Q4 2021 and held it in 9 quarters. The position peaked at $1.99M in Q4 2021. 120 funds tracked by Wall St. Rank hold SKIN as of Q1 2024.

  • UBS AM reported no remaining SkinHealth Systems position as of Q1 2024 after selling out during the quarter.
  • UBS AM sold 99,546 SkinHealth Systems shares in Q1 2024, an estimated $310K.
  • UBS AM first reported a position in SkinHealth Systems in Q4 2021 and held it in 9 quarters.
  • UBS AM's SkinHealth Systems position peaked at $1.99M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2024.

Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.